Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439589
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-28
Brief Title:
Phase IbII Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co Ltd
Organization:
Shanghai Hengrui Pharmaceutical Co Ltd
Organization Data
Organization:
Shanghai Hengrui Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
HRS2398-201-PD-L1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None